Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/03/2012US8148362 Compound having heterocyclic ring
04/03/2012US8148361 Kinase inhibitors
04/03/2012US8148360 Supramolecular metallic complexes exhibiting both DNA binding and photocleavage
04/03/2012US8148359 Chelating agents of metal ions, their methods of preparation and their applications
04/03/2012US8148358 Blue colour filters with enhanced contrast
04/03/2012US8148356 Acetylcysteine composition and uses therefor
04/03/2012US8148355 Phophylactic and therapeutic use of hydroxysteroids
04/03/2012US8148354 Use of 20(S)-protopanaxadiol in manufacture of antidepressants
04/03/2012US8148353 Polymorphs of fluticasone furoate and process for preparation thereof
04/03/2012US8148352 Antimicrobial therapy for bacterial infections
04/03/2012US8148351 Enteropathy ameliorating composition
04/03/2012US8148350 Carbohydrate composition for flat glucose response
04/03/2012US8148349 Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
04/03/2012US8148348 Method of stabilizing S-adenosyl-L-methionine and stabilized composition
04/03/2012US8148345 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
04/03/2012US8148344 Compositions and methods for mediating RNAi in vivo
04/03/2012US8148342 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
04/03/2012US8148340 Immunomodulatory oligonucleotides
04/03/2012US8148339 Method of reducing cardiac levels of doxorubicin when given as orotate salt
04/03/2012US8148338 Doxorubicin formulations for anti-cancer use
04/03/2012US8148337 Vaginal compositions for treating pelvic tissue infections and traumas
04/03/2012US8148335 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
04/03/2012US8148334 Peptides with capacity for binding with interleukine 10 (IL-10)
04/03/2012US8148327 Aldosterone induced elastin production
04/03/2012US8148325 Improved alertness, vitality, cartilage protection, maintenance of muscle mass, and skin and pelage quality; feeding the cat, dog or horse a food with at least 9% protein, 5% fat, and 0.05% of at least one omega-3 polyunsaturated fatty acid
04/03/2012US8148321 Bioconjugates as therapeutic agent and synthesis thereof
04/03/2012US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
04/03/2012US8148114 Materials and methods for treatment of inflammatory and cell proliferation disorders
04/03/2012US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof
04/03/2012US8147873 Methods and compositions for treatment of ion imbalances
04/03/2012US8147872 Pharmaceutical compositions of drugs and neutralized acidic polymers
04/03/2012US8147870 Oral drug delivery system
04/03/2012US8147869 Liposome-encapsulated glutathione for oral administration
04/03/2012US8147866 Transmucosal delivery devices with enhanced uptake
04/03/2012US8147864 Implants for administering substances and methods of producing implants
04/03/2012US8147863 Polyarylates for drug delivery and tissue engineering
04/03/2012US8147857 Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressings
04/03/2012US8147855 Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium
04/03/2012US8147852 Modified azole compounds as antifungal and antibacterial agents
04/03/2012US8147851 With cetyl myristate alone or in admixture with cetyl palmitate
04/03/2012US8147826 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
04/03/2012US8147823 Method of treating or retarding the development of blindness
04/03/2012US8147818 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials
04/03/2012US8147816 Presbyopia treatment by lens alteration
04/03/2012US8147815 Topical administration carrier composition and therapeutic formulations comprising same
04/03/2012US8147811 Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
04/03/2012US8147809 Soft anticholinergic esters
04/03/2012US8147698 Process for metabolic control and high solute clearance and solutions for use therein
04/03/2012US8147540 Taxane coatings for implantable medical devices
04/03/2012DE202012001673U1 Lösungen zur Behandlung von Obstipation und/oder Impaktbildung Solutions for the treatment of constipation and / or impaction
04/03/2012DE202011108341U1 Medikament Drug
04/03/2012CA2756674C Microemulsion & sub-micron emulsion process & compositions
04/03/2012CA2677872C A composition for selective serotonin reuptake inhibition and process thereof
04/03/2012CA2674369C Fused substituted aminopyrrolidine derivative
04/03/2012CA2648945C Chemoprotective methods and compositions
04/03/2012CA2648157C 1-alkyl-5-aryl-3-arylamino-1h-1,2,4-triazoles as positive allosteric modulators of the alpha 7 receptor
04/03/2012CA2624481C Anti-hypercholesterolemic compounds
04/03/2012CA2620250C A process for the removal of sterols and other compounds from glycerol oils
04/03/2012CA2617725C Novel cysteine protease inhibitors and their therapeutic applications
04/03/2012CA2613015C Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors
04/03/2012CA2593010C Process for the preparation of tamsulosin and intermediates thereof
04/03/2012CA2582316C Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
04/03/2012CA2569683C Oral antimicrobial pharmaceutical compositions
04/03/2012CA2566464C Synthesis of tetracyclines and analogues thereof
04/03/2012CA2537041C Modified release compositions comprising tacrolimus
04/03/2012CA2528590C 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
04/03/2012CA2513910C Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
04/03/2012CA2513281C Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
04/03/2012CA2508692C Combination medicament
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
04/03/2012CA2501546C Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
04/03/2012CA2493812C Novel imidazole compounds, method for preparing same and use thereof as medicines
04/03/2012CA2491801C Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology
04/03/2012CA2487789C Composition for improving melasma and composition for reducing skin dullness
04/03/2012CA2472650C Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
04/03/2012CA2467759C Use of nanoparticles as carriers for biocides in ophthalmic compositions
04/03/2012CA2434930C Treating pulmonary disorders with gaseous agent causing repletion of gsno
04/03/2012CA2432792C Methods for modulating tumor growth and metastasis
04/03/2012CA2423744C Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
04/03/2012CA2398445C A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
04/03/2012CA2339066C Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
04/03/2012CA2294981C Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
04/03/2012CA2294031E Self-emulsifying formulation for lipophilic compounds
04/01/2012CA2716264A1 Use of ganglioside to decrease propagation of malignant prostate cells
04/01/2012CA2716236A1 Compositions for the treatment of hcv and hbv
03/2012
03/29/2012WO2012040719A2 Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
03/29/2012WO2012040707A2 Materials and methods for improving gastrointestinal function
03/29/2012WO2012040651A2 Controlled release formulations of opioids
03/29/2012WO2012040641A2 Compounds for treating neurodegenerative diseases
03/29/2012WO2012040636A2 Compounds and methods for treating diseases mediated by protease activated receptors
03/29/2012WO2012040634A1 Atropisomers of pi3k-inhibiting compounds
03/29/2012WO2012040633A1 Compounds that enable alternative mitochondrial electron transfer
03/29/2012WO2012040623A2 Nanostructured gels capable of controlled release of encapsulated agents
03/29/2012WO2012040595A2 Administration of serine protease inhibitors to the stomach
03/29/2012WO2012040532A1 Substituted oxadiazole compounds and their use as s1p1 agonists
03/29/2012WO2012040527A2 Deubiquitinase inhibitors and methods for use of the same
03/29/2012WO2012040523A2 Phosphohistidine analogs
03/29/2012WO2012040511A2 Compounds that modulate intracellular calcium
03/29/2012WO2012040499A2 Metabolic inhibitors
03/29/2012WO2012040492A1 Methods of treating cancer comprising targeting nqo1
1 ... 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 ... 7860